Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Zepp Health (ZEPP) Enterprise Value (2016 - 2025)

Zepp Health has reported Enterprise Value over the past 11 years, most recently at -$112.9 million for Q4 2025.

  • For Q4 2025, Enterprise Value fell 3.04% year-over-year to -$112.9 million; the TTM value through Dec 2025 reached -$112.9 million, down 3.04%, while the annual FY2025 figure was -$112.9 million, 10015.1% down from the prior year.
  • Enterprise Value for Q4 2025 was -$112.9 million at Zepp Health, up from -$102.6 billion in the prior quarter.
  • Over five years, Enterprise Value peaked at -$109.6 million in Q4 2024 and troughed at -$131815.8 billion in Q4 2023.
  • A 5-year average of -$6667.8 billion and a median of -$98.9 billion in 2025 define the central range for Enterprise Value.
  • Biggest five-year swings in Enterprise Value: tumbled 103186031.72% in 2023 and later skyrocketed 100.0% in 2024.
  • Year by year, Enterprise Value stood at -$230.7 million in 2021, then soared by 44.62% to -$127.7 million in 2022, then tumbled by 103186031.72% to -$131815.8 billion in 2023, then skyrocketed by 100.0% to -$109.6 million in 2024, then decreased by 3.04% to -$112.9 million in 2025.
  • Business Quant data shows Enterprise Value for ZEPP at -$112.9 million in Q4 2025, -$102.6 billion in Q3 2025, and -$95.3 billion in Q2 2025.